Skip to main content

Table 2 The operative characteristics of patients compared by use of DHCA

From: The role of deep hypothermic circulatory arrest in surgery for renal or adrenal tumor with vena cava thrombus: a single-institution experience

Variable DHCA P
No Yes
Operative duration,min    0.00
n 12 21  
 Mean(median) 267.9(96.7) 521.9(120.6)  
EBL,ml    0.01
n 12 21  
 Mean(median) 854.3(863.8) 5933.7(8040)  
Transfusions,n
n 5 21  
 Mean(median) 4.8(3.1) 17.22(11.67)  
ICU stay,days
n 1 21  
 Mean(median) 6 6.4(1.3)  
Hospital stay,days    0.00
n 12 33  
 Mean(median) 13.8(4.4) 28.5(14.3)  
Perioperative mortality,n    0.58
n 12 21  
N(%)deaths 0 1(4.7)  
Tumor pathology
 renal clear cell carcinoma 5(41.7) 8(38.1)  
 renal cell carcinoma 3(0.25) 5(23.8)  
 adrenocortical 2(16.7) 4(19.0)  
 Whilms tumor 2(16.7) 3(14.3)  
 renal pelvic transitional carcinoma 0 1(4.7)